Stay updated on Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T07:40:14.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T04:56:06.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T06:25:51.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about squamous cell carcinoma of the head and neck and the addition of a new study titled 'Immunomodulation of Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (HNSCC) After Platinum Failure'.
    Difference
    49%
    Check dated 2025-04-15T20:41:14.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T16:16:52.000Z thumbnail image
  8. Check
    115 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T09:53:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.